Assembly Biosciences Inc.
(ASMB)
undefined
undefined%
At close: undefined
15.38
0.20%
After-hours Dec 13, 2024, 03:59 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
| Net Income | -61.23M | -93.09M | -129.85M | -62.15M | -97.63M | -90.75M | -42.81M | -44.26M | -28.45M | -23.79M | -19.40M | -24.79M | -34.34M | -15.29M | -4.54M | -8.79M |
| Depreciation & Amortization | 450.00K | 498.00K | 466.00K | 691.00K | 494.00K | 643.00K | 219.22K | 80.25K | 64.99K | 10.97K | 6.22K | 4.62K | 3.75K | 12.53K | 7.51K | 4.65K |
| Stock-Based Compensation | 5.12M | 6.59M | 5.24M | 21.85M | 20.56M | 28.48M | 8.60M | 5.02M | 7.88M | 11.32M | 1.71M | 3.17M | 2.98M | 2.36M | 123.76K | 460.82K |
| Other Working Capital | 77.47M | -1.35M | -6.25M | -28.06M | -3.61M | -5.02M | 45.70M | 2.75M | 1.33M | -30.70K | 107.29M | 234.93K | 1.97M | 3,049.60B | 39.88K | 2.58M |
| Other Non-Cash Items | 9.21M | 3.66M | 44.69M | 6.96M | 2.82M | -229.00K | 615.13K | 1.14M | 7.88M | 679.45K | 1.71M | 3.17M | 3.99M | 8.45M | 767.39K | 902.93K |
| Deferred Income Tax | -7.15M | - | -2.53M | -4.00K | -774.00K | 1.10M | -9.05M | -617.67K | -7.85M | -679.45K | -1.71M | -3.17M | 328.96K | 2.33M | 116.95K | 692.91K |
| Change in Working Capital | 76.34M | -2.12M | -11.40M | -30.31M | -9.53M | -4.21M | 44.28M | 3.75M | 1.79M | -2.51M | -111.49K | 234.93K | 1.97M | -3.07M | 39.88K | 2.58M |
| Operating Cash Flow | 22.74M | -84.46M | -93.40M | -62.96M | -84.07M | -64.96M | 1.86M | -34.88M | -18.70M | -14.97M | -17.80M | -21.38M | -25.07M | -5.21M | -3.48M | -4.15M |
| Capital Expenditures | -255.00K | -102.00K | -3.10M | -2.22M | -1.55M | -340.00K | -864.56K | -146.33K | -58.26K | -149.96K | -6.48K | -3.24K | -11.96K | - | -2.57K | -2.88K |
| Acquisitions | - | 1.50M | 1.50M | 1.75M | -1.74M | -48.88M | -33.18B | -36.20B | 150.00 | 509.36K | - | - | - | - | - | - |
| Purchase of Investments | -133.92M | -27.58M | -160.45M | -193.19M | -281.33M | -183.94M | -48.23M | -7.95M | -69.78M | - | - | - | - | - | - | - |
| Sales Maturities Of Investments | 65.02M | 116.83M | 187.70M | 263.48M | 232.57M | 48.88M | 33.46M | 44.29M | 4.98M | - | - | - | - | - | - | - |
| Other Investing Acitivies | 24.00K | 90.74M | 857.00K | -1.75M | 1.74M | 48.88M | 33.18B | 36.20B | 150.00 | -82.00K | - | - | - | - | - | - |
| Investing Cash Flow | -69.14M | 90.64M | 26.52M | 68.07M | -50.32M | -135.40M | -15.64M | 36.20M | -64.86M | 277.40K | -6.48K | -3.24K | -11.96K | - | -2.57K | -2.88K |
| Debt Repayment | - | - | - | - | - | - | - | - | - | - | - | - | -2.79M | 5.27M | 3.63M | 1.67M |
| Common Stock Repurchased | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Financial Acitivies | 129.00K | 289.00K | 258.00K | 2.15M | 4.99M | 4.37M | 2.39M | - | 554.27K | - | - | 730.32K | 288.73K | -755.09K | -76.46K | -312.85K |
| Financial Cash Flow | 13.82M | 614.00K | 53.06M | 7.60M | 139.65M | 159.79M | 67.24M | 152.64K | 81.57M | 16.73M | 24.37M | 4.90M | 47.49M | 19.70M | 3.55M | 2.50M |
| Net Cash Flow | -32.58M | 6.79M | -13.82M | 12.71M | 5.26M | -40.56M | 53.46M | 1.47M | -1.98M | 2.03M | 6.57M | -16.49M | 22.40M | 14.49M | 65.44K | -1.65M |
| Free Cash Flow | 22.49M | -84.56M | -96.49M | -65.18M | -85.62M | -65.30M | 995.52K | -35.03M | -18.76M | -15.12M | -17.80M | -21.38M | -25.08M | -5.21M | -3.49M | -4.15M |